FDA — authorised 15 July 2015
- Application: NDA207917
- Marketing authorisation holder: GALDERMA LABS
- Local brand name: EPIDUO FORTE
- Indication: GEL — TOPICAL
- Status: approved
FDA authorised Epiduo® Forte Gel on 15 July 2015
Yes. FDA authorised it on 15 July 2015.
GALDERMA LABS holds the US marketing authorisation.